Cidara Therapeutics Inc (NASDAQ:CDTX) Posts Basic Consolidated EPS Of $-3.2453

0

Cidara Therapeutics Inc (NASDAQ:CDTX)managed to report annual basic consolidated EPS of $-3.2453, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-3.2453 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.8474.

EPS contribution from parent

Cidara Therapeutics Inc (NASDAQ:CDTX) received of $-3.2453 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Cidara Therapeutics Inc (NASDAQ:CDTX) contributed EPS of $-3.2453 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-3.2453.

What About Basic net EPS

The basic net EPS that Cidara Therapeutics Inc (NASDAQ:CDTX) reported for the year ended 2015-12-31 stood at $-3.25. For the quarter ended 2015-12-31, the company posted basic net EPS of $-3.25.

What About Consolidated Diluted EPS?

Cidara Therapeutics Inc (NASDAQ:CDTX)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-3.2453. For the quarter ended 2015-12-31 the metric was$-3.2453.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-3.2453 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-3.2453.

Net diluted EPS

Net diluted EPS posted by Cidara Therapeutics Inc (NASDAQ:CDTX) for the year ended 2015-12-31 was $-3.25. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-3.25.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Cidara Therapeutics Inc (NASDAQ:CDTX) said that it parent company boosted its diluted EPS by$-3.2453 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-3.2453.

The company reported net basic EPS of $-3.25 for the year ended 2015-12-31 and net basic EPS of $-3.25 for the quarter ended 2015-12-31.

The number of Cidara Therapeutics Inc (NASDAQ:CDTX)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 9.92. That compares with 9.92 basic shares outstanding for the quarter ended 2015-12-31.

Cidara Therapeutics Inc (NASDAQ:CDTX) had 9.92 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 9.92.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 12 times, 1 visits today)